Viewing Study NCT00153803


Ignite Creation Date: 2025-12-24 @ 7:23 PM
Ignite Modification Date: 2025-12-25 @ 5:02 PM
Study NCT ID: NCT00153803
Status: COMPLETED
Last Update Posted: 2019-09-06
First Post: 2005-09-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Dartmouth-Hitchcock Medical Center
Organization: